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A B S T R A C T
We describe two male patients with focal epilepsy in whom transitory episodes of atrial ﬁbrillation (AF)
lasting for up to 25 h were detected in the context of generalized tonic–clonic seizures (GTCSs). In ﬁve of
seven previously published cases of transitory AF associated with epileptic seizures, AF was also
associated with GTCS, suggesting a pathophysiological link via GTCS-related increase in sympathetic
tone and release of catecholamines. Importantly, AF increases the risk of thromboembolic cerebral
ischemia, prompting the question of whether antithrombotic preventive treatment should be initiated in
people with pharmacoresistant epilepsy and prolonged peri-ictal AF. Furthermore, AF can considerably
impair cardiac output and may, via this mechanism, contribute to the risk of sudden unexpected death in
epilepsy following GTCS.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Generalized tonic–clonic seizures (GTCSs) are commonly
associated with central apnea and sustained sinus tachycardia.
Potentially serious cardiac arrhythmias are very rare and include
sinus bradycardia, asystole and ventricular tachyarrhythmia.1
Here, we describe two patients with prolonged atrial ﬁbrillation
(AF) detected in the context of GTCSs. We review the previously
reported cases and discuss possible pathophysiological mecha-
nisms and treatment considerations.
2. Case reports
2.1. Case 1
This is a 23-year-old left-handed man with pharmacoresistant
focal epilepsy since the age of 17 manifesting with infrequent
variable auras (feeling ‘‘unwell’’, somewhat ‘‘dizzy’’ or being aware
of tingling in the right or left hand) developing into secondarily
GTCS (about 3 per year). Seizures had occurred from the sleeping
and waking state and lasted between 2 and 3 min. Repeated
routine scalp-EEG recordings were unremarkable. Cerebral MRI* Corresponding author at: Department of Epileptology, University Hospital
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junction of grey and white matter with an emphasis in the left
parietal lobe. Although these ﬁndings together with presence of
oligoclonal bands in the CSF were suggestive of neurocysticercosis
or a chronic inﬂammatory process, subsequent extensive screening
for speciﬁc antibodies (including HIV) in blood and CSF were
normal and have not supported this hypothesis. Typical risk factors
for epilepsy were absent (no febrile seizures, no head/brain injury,
no known CNS inﬂammation, negative family history for epilepsy)
and interictal neurological and general examinations were normal.
This patient was admitted to our hospital 45 min after a GTCS.
Clinical examination was normal apart from an irregular heart
rhythm with a rate of around 60 beats per minute (bpm). A 12-lead
electrocardiogram (ECG) conﬁrmed the presence of AF. Video-EEG
telemetry was started 24 h after the GTCS and revealed no EEG-
abnormality during a 48-h recording period. During the recording
period the patient was medicated with lamotrigine (LTG, 300 mg
per day) and levetiracetam (LEV, 2000 mg per day). On the
continuous one-lead ECG during video-EEG telemetry, AF was still
present on the day after admission and spontaneously resolved
about 25 h after the GTCS (Fig. 1). Blood pressure was normal (110–
120/60–80 mm Hg, heart rate 60–70 bpm) during AF and did not
change after the spontaneous remission of the AF. Cardiological
evaluation with a transthoracic echocardiogram was normal
(normal dimension of cardiac cavities without signs of atrial
enlargement). The patient was given 100 mg aspirin per day and
47.5 mg metoprolol per day for some weeks. Repeated ambulatory
Holter-recordings were recommended (but had not been done at
last follow-up 5 months later). The LEV dose was increased tovier Ltd. All rights reserved.
Fig. 1. Continuous one-lead ECG during video-EEG-telemetry displayed AF (upper
trace and ﬁrst part of the lower trace) which spontaneously remitted about 25 h
after GTCS (indicated by an arrow in the lower trace). Insets: A short portion of the
ECG trace during AF and after remission was magniﬁed for easier analysis.
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prior to the current admission, cardiological examinations were
already performed because of transitory AF with rapid heart rate in the
context of a GTCS (while taking 250 mg LTG per day). All subsequent
examinations including transthoracic echocardiogram, 24 h Holter-
recording and exercise testing carried out at that time were normal.
2.2. Case 2
This is a 25-year-old right-handed man with pharmacoresistant
focal epilepsy since the age of 7 manifesting with complex-partial
seizures (staring, impaired consciousness and complex automa-
tisms or acoustic auras and sensory aphasia). On LTG (400 mg per
day), LEV (4000 mg per day) and valproate (1000 mg per day)
seizures occurred in clusters with a frequency of about 3 per week
and a duration of 1–2 min. In addition, the patient reported 6–12
secondarily GTCSs a year. Cerebral MRI (3 T) revealed a mesio-
temporal dysembryoplastic tumor of the left hemisphere. In view
of concordant electro-clinical and MRI ﬁndings, the patient
underwent epilepsy surgery (resection of the anterior temporal
lobe including mesio-temporal structures). At the time of his last
follow-up 6 months after epilepsy surgery he was seizure-free on
LTG (500 mg per day) and LEV (3000 mg per day).
Prior to epilepsy surgery, this patient had suffered from a GTCS
causing a minor head injury and laceration of the scalp, prompting
referral to an adjacent hospital. On admission into the intensive
care unit, he presented with rapid AF which spontaneously
resolved after several hours. Based on the time of seizure-onset andTable 1
Review of reported seizure-related episodes with AF.
Case Sex/age Epilepsy/origin Seizurea Anti
1 F/74 JME GTCS n.r. 
2 M/47 ‘‘Symptomatic epilepsy’’ GTCS n.r. 
3 n.r./n.r. n.r./n.r. GTCS n.r. 
4 n.r./22d IGE GTCS n.r. 
5 n.r./34d Focal/n.r. CPS n.r. 
6 n.r./n.r. n.r./n.r. n.r. n.r. 
7 M/45 IGE? GTCS None
8 M/23 Focal/unknown origin GTCS LEV,
9 M/25 Focal/DNT GTCS LCM
n.r., not reported.
CPS, complex-partial seizure; DNT, dysembryoplastic neuroepithelial tumor; GTCS, ge
myoclonic epilepsy; LCM, lacosamide; LEV, levetiracetam; LTG, lamotrigine.
a Seizure type preceding detection of AF.
b Anticonvulsant drugs at the time of AF.
c Clinical signs related to AF.
d Died of SUDEP.
e Spontaneous remission.
f Remitted upon intravenous administration of digoxine and verapamil.
g Remitted upon intravenous administration of propafenone.arrival in the hospital, the estimated duration of AF amounted to a
minimum of 3 h. Blood pressure was normal or transiently
elevated (up to 170/60 mm Hg) during and after the AF episode.
Additional cardiological examinations, apart from a 12-lead ECG,
have not been performed. At the time of this episode, the patient
was on LEV (3000 mg per day), LTG (300 mg per day) and
lacosamide (LCM, 100 mg per day).
3. Discussion
Sinus tachycardia is frequently observed during or after
seizures, whereas peri-ictal bradyarrhythmias including sinus
bradycardia and asystole, atrioventricular conduction block and
marked sinus arrhythmia are less common.1,2 Seizure-related AF
appears to be very rare and is usually of short duration. To date,
only a few episodes of AF lasting up to 2 h have been reported in
people with epilepsy (Table 1). Here, we describe two patients with
chronic epilepsy in whom prolonged episodes of AF lasting up to
25 h were detected in the context of GTCSs.
3.1. Study limitations
The major weakness of our cases is the fact that the onset of AF
has not been recorded during continuous video-EEG telemetry, but
that AF was only recognized on admission in the hospital after a
GTCS at home. It is important to note that AF is clinically silent
without any symptoms in about one third of people with AF.3 Thus,
we cannot rule out that in our two patients AF has occurred
independently of the generalized seizures. Known triggering or
facilitating factors of AF such as thyroid dysfunction, excessive
alcohol-consumption or other medical conditions associated with
AF were not present in our patients.4,5 Anticonvulsant drugs may
also facilitate the onset of AF. For instance LCM has recently been
reported to be associated with AF in a patient with epilepsy on
600 mg LCM per day.6 In this patient, AF remitted on discontinua-
tion of LCM. In our case 2, AF was detected following a GTCS while
the patient was on three anticonvulsant drugs including LCM.
Although LCM was used at a low dose, a causal or permissive
relationship between LCM administration and onset of AF cannot
be ruled out.
3.2. Pathophysiological mechanism of seizure-related AF
Seven cases of seizure-related AF have previously been reported
(Table 1).7–11 In ﬁve of these patients, AF was detected in theconvulsantsb AF duration Clinical signsc Reference
2 he n.r. [8]
n.r.f n.r. [8]
10 se n.r. [9]
>110 se n.r. [10]
55 se n.r. [10]
n.r. n.r. [11]
 60g and 90emin n.r. [7]
 LTG 25 he None Our case 1
, LEV, LTG >3 he None Our case 2
neralized tonic–clonic seizure; IGE, idiopathic generalized epilepsy; JME, juvenile
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cases of seizure-related AF were recognized following GTCSs,
strongly suggesting a pathophysiological link between the onset of
AF and GTCS. This apparent association, however, could also be due
to a selection bias for GTCS, as these patients are often immediately
referred to a hospital where ECG recordings are routinely
performed on admission. Nevertheless, several arguments are in
favor of the hypothesis that AF was induced by GTCSs in our two
patients: (i) Both patients have denied interictal symptoms
suggestive of cardiac arrhythmia such as palpitations or syncope
(although this is a weak point, since up to one third of people with
AF have no clinical symptoms)3; (ii) both patients had no apparent
cardiological disease, and interictal cardiac diagnostic work-up
including cardiac Holter-monitoring in the absence of GTCS was
normal; (iii) in our patient 1, AF was detected twice following
GTCSs. Repeated AF after GTCS was also recently described by
Vedovello et al.7; (iv) GTCSs are associated with a massive release
of catecholamines12; (v) adrenergic/sympathetic stimulation is
implicated in the generation of AF,13,14 potentially linking GTCS
and occurrence of AF.
3.3. Clinical implications and treatment considerations
Paroxysmal or permanent AF is an important risk factor for
thromboembolic ischemic stroke.15 Furthermore, irregular heart
activity with slow or fast heart rate may impair cardiac output with
consecutive clinical symptoms. Thus, increased mortality, an
increased risk for stroke and potential impairment of cardiac
function prompt the questions if and how transient seizure-related
AF has to be treated. Medical treatment of AF basically involves
antithrombotic treatment on the one hand and the control of heart
rate and rhythm on the other hand.4 In view of the young age of our
two patients and the absence of other risk factors, the stroke risk
was low, so that permanent antithrombotic medication was not
thought to be indicated.15 In this context, it is important to stress
that antithrombotic treatment in people with frequent GTCSs and
consecutive falls should be considered with caution and, in view of
the increased risk of head injury and intracranial hemorrhage, may
better be avoided. The management of heart rate and rhythm
includes the question of whether conversion of AF into sinus
rhythm is necessary and whether potential alterations of heart rate
lead to symptoms. Cardiological conversion therapy and long-term
administration of drugs for rate control were not considered in our
two cases, as AF reconverted spontaneously. In view of the
probable pathophysiological link between GTCS, adrenergic/
sympathetic hyperactivity and onset of AF, however, long-term
administration of beta-blockers (which are commonly used for
rate and rhythm control in people with AF) may be considered in
people with pharmacoresistant epilepsy and seizure-related AF.
Our ﬁndings may also be of some importance in the context of
sudden unexpected death in epilepsy (SUDEP). AF is associated
with increased mortality predominantly due to complications of
ischemic stroke.16 AF, however, can also cause considerable
impairment of ventricular output (especially with tachycardia)
even in the absence of structural heart disease.3 Therefore, peri-
ictal AF may also contribute to an increased risk of SUDEP; GTCSbeing a major risk factor for SUDEP.1 Interestingly, peri-ictal AF has
been observed in two patients who died of SUDEP later on (Table
1), supporting the hypothesis of a potential contribution of AF to
SUDEP.10
In conclusion, transitory AF is a rare complication of GTCSs. It is
unclear whether seizure-related AF requires speciﬁc treatment.
The best prevention appears to be full seizure-control. Interdisci-
plinary care may be considered in people with chronic epilepsy,
repeated episodes of prolonged peri-ictal AF and co-factors which
are associated with an increased risk of thromboembolic stroke or
disturbances of heart rate with consecutive complications.15
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